Table 1 Comparison of demographic and clinical characteristics of patients according to permanent pacemaker implantation in the follow-up
Permanent pacemaker implantation (−) in follow-up n = 128 | Permanent pacemaker implantation (+) in follow-up n = 49 | p value | |
|---|---|---|---|
Age (years) | 76 (66–83) | 73 (65–80) | 0.286 |
Male gender | 54 (42.2%) | 21 (42.9%) | 0.936 |
Hypertension | 99 (77.3%) | 42 (85.7%) | 0.203 |
Diabetes Mellitus | 62 (48.4%) | 21 (42.9%) | 0.505 |
Hyperlipidemia | 29 (22.7%) | 12 (24.5%) | 0.797 |
Smoking | 12 (9.4%) | 2 (4.1%) | 0.355 |
Chronic renal failure | 45 (35.2%) | 12 (24.5%) | 0.167 |
Congestive heart failure | 18 (14.1%) | 8 (16.3%) | 0.706 |
Chronic obstructive pulmonary disease | 18 (14.1%) | 3 (6.1%) | 0.121 |
Alzheimer | 6 (4.7%) | 1 (2.0%) | 0.675 |
Coronary artery disease | 47 (36.7%) | 20 (40.8%) | 0.616 |
Percutaneous coronary intervention | 28 (21.9%) | 7 (14.3%) | 0.245 |
Coronary artery bypass grafting | 23 (18.0%) | 8 (16.3%) | 0.796 |
Myocardial infarction | 37 (28.9%) | 14 (28.6%) | 0.965 |
Cerebrovascular accident | 10 (7.8%) | 1 (2.0%) | 0.294 |
Paroxysmal atrial fibrillation | 0 (0.0%) | 1 (2.0%) | 0.277 |
Permanent atrial fibrillation | 26 (20.3%) | 5 (10.2%) | 0.098 |
Hospitalization period, days | 7 (5–10) | 9 (6–12) | 0.186 |
Follow-up | 33 (17–61) | 52 (26–89) | |
Time to permanent pacemaker implantation, months | 10 (3–23) |